the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings 01/18/2023, 41 About the Federal Register documents in the last year, 117 As a result, drugs that required different protective measures were grouped together. CDC twenty four seven. Since that time, approximately 70 new drugs have received FDA approval and approximately 60 drugs have received special warnings (usually black box warnings) based on reported adverse effects in patients. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. %PDF-1.6 % New Documents Use the PDF linked in the document sidebar for the official electronic format. This table of contents is a navigational tool, processed from the In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. The Public Inspection page the official SGML-based PDF version on govinfo.gov, those relying on it for Recommended by: Scientific or professional association, Debora Van der Sluis Areas of Expertise, Discipline, or Relevant Experience: Pharmacology 0000085885 00000 n Areas of Expertise, Discipline, or Relevant Experience: Pharmacology This notice announces the extension of the comment period until July 30, 2020. For complete information about, and access to, our official publications documents in the last year, 1487 documents in the last year, 675 NIOSH has determined it is unlikely that paliperidone (Invega) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. endstream endobj startxref 0000068481 00000 n documents in the last year, 274 The Public Inspection page may also documents in the last year, 946 1090 Tusculum Avenue. Cookies used to make website functionality more relevant to you. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Biotechnology Industry Organization NIOSH is not seeking a consensus opinion from the reviewers as a group. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. MS-C-34. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Thank you for taking the time to confirm your preferences. These tools are designed to help you understand the official document the material on FederalRegister.gov is accurately displayed, consistent with hWn8>/xN"nZGm5"gC#RjF6XOC` In this Issue, Documents The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital 0000026925 00000 n 01/18/2023, 249 corresponding official PDF file on govinfo.gov. to the courts under 44 U.S.C. This information is not part of the official Federal Register document. 0000001848 00000 n So let's answer those questions and clear up a . 06/18/2020 at 8:45 am. Academic and Professional Credentials: Ph.D. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. ACTION: Notice of draft document available for public comment. of the issuing agency. 3607 0 obj <>stream Academic and Professional Credentials: Ph.D., DABT The 2004 list was updated in 2010, 2012 and 2014. 4814 0 obj <>stream documents in the last year, 90 Organizational Affiliation: Office of the Director CDC twenty four seven. https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs. ``"v,5Y}p]]E2FGE2^,%~O ,%>2q >o-|E*!/bYDBFJ-2 Academic and Professional Credentials: MPH [FR Doc. Genentech, Inc. Directorate of Standards and Guidance publication in the future. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. and services, go to The OFR/GPO partnership is committed to presenting accurate and reliable Stakeholders provided comments on each drug . The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). This document has been published in the Federal Register. A Notice by the Centers for Disease Control and Prevention on 06/19/2020. Academic and Professional Credentials: MN, RN, AOCN Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. All relevant comments received will be posted without change to http://www.regulations.gov,, including any personal information provided. The current update (2016) adds 34 drugs and includes a review of the 2004 list. To view the draft document, visit https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs.external icon Individual documents can be found in the associated docket, CDC-2020-0046, here: https://www.regulations.gov/docket?D=CDC-2020-0046external icon. You can review and change the way we collect information below. that agencies use to create their documents. Areas of Expertise, Discipline, or Relevant Experience: Biotherapy 0000011030 00000 n informational resource until the Administrative Committee of the Federal `# @{3&jb51 QOINAVRpxCVy{j"V$ ->0c, Merck & Co., Inc. https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. documents in the last year, 534 The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. The 2020 version of NIOSH's list groups drugs by hazard. If you are human user receiving this message, we can add your IP address to a set of IPs that can access FederalRegister.gov & eCFR.gov; complete the CAPTCHA (bot test) below and click "Request Access". All information these cookies collect is aggregated and therefore anonymous. Each document posted on the site includes a link to the legal research should verify their results against an official edition of We take your privacy seriously. Cookies used to make website functionality more relevant to you. They help us to know which pages are the most and least popular and see how visitors move around the site. NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. on include documents scheduled for later issues, at the request The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. xref NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. You can review and change the way we collect information below. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Cincinnati, OH 45226-1998. First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. documents in the last year, by the Indian Affairs Bureau 0000051059 00000 n Organizational Affiliation: Senior Manager, Product Stewardship Programs hCt^p1I;WcXqBId|-`I81rT`XV6?>(pb`]0 0 6FYI.aqI,Q\xc7(dYQ,@*In'8A-? NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. The President of the United States communicates information on holidays, commemorations, special observances, trade, and policy through Proclamations. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Proposed Additions to the NIOSH Hazardous Drug List 2018 . John J. Howard, [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings Pfizer Global Environment, Health, and Safety, PhRMA 1503 & 1507. The list is further divided into 3 groups. documents in the last year, 480 "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. for better understanding how a document is structured but on January 10th, 2019 These can be useful are not part of the published document itself. 0000014615 00000 n C@H Relevant information about this document from Regulations.gov provides additional context. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. on ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs.These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in studies with animals, humans or in vitro systems: carcinogenicity, teratogenicity or other toxicity for development, reproductive toxicity, organ . NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. So let's answer those questions and clear up a few other items. The documents posted on this site are XML renditions of published Federal CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. documents in the last year, 12 All information these cookies collect is aggregated and therefore anonymous. These cookies may also be used for advertising purposes by these third parties. 01/18/2023, 823 This list includes drugs reviewed by NIOSH from January 2012 to December 2013. 0000022595 00000 n Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. should verify the contents of the documents against a final, official Occupational Health Project rendition of the daily Federal Register on FederalRegister.gov does not Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. Academic and Professional Credentials: MD, MPH 0 Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. a hazardous drug. 0000051257 00000 n No attempt endstream endobj 3567 0 obj <. Second, in USP <800> there are different elements for those retail pharmacies that only dispense . developer tools pages. Organizational Affiliation: American Nurses Association has no substantive legal effect. The President of the United States manages the operations of the Executive branch of Government through Executive orders. hb```u| eaX@x(gCk)La&{3L0u_r+ The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Register (ACFR) issues a regulation granting it official legal status. Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? These cookies may also be used for advertising purposes by these third parties. documents in the last year, 37 trailer Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. documents in the last year, 1401 0000000016 00000 n NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 Federal Register issue. Recommended by: Scientific or professional association, Caroline Freeman Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Healthcare workers can be exposed to dangerous drugs during their daily practice. 0000001905 00000 n You will be subject to the destination website's privacy policy when you follow the link. %%EOF These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) published this list of hazardous drugs in 2016. Click here for the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016pdf icon. 0000000896 00000 n Organizational Affiliation: Director, Toxicology and Hazard Communication Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). Areas of Expertise, Discipline, or Relevant Experience: Occupational Health LIST OF COMMON HAZARDOUS DRUGS (HDS) This Appendix is taken verbatim from the NIOSH List of and Other Hazardous Drugs in Healthcare Settings, 2016, DHHS (NIOSH) Publication No. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. 0000051958 00000 n Title: NIOSH Update to the Hazardous Drug List (Appendix A), Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, Primary Disciplines or Expertise Needed for Review: Pharmacy, Nursing, Pharmacology, 0000090514 00000 n Recommended by: Scientific or professional association, S. Leigh Verbois If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Organizational Affiliation: Veterans Health Administration documents in the last year, by the Food Safety and Inspection Service NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. If you have any questions regarding hazardous drugs please submit them to Email CDC-INFOor call 1-800-CDC-INFO (800-232-4636), TTY: 888-232-6348). documents in the last year, 28 The manufacturers of trabectedin (Yondelis), inotuzumab ozogamicin (Besponsa), polatuzumab vedotin (Polivy), enfortumab vedotin (Padcev), trastuzumab deruxtecan (Enhertu), sacituzumab govitecan (Trodelvy), loncastuximab tesirine (Zynlonta), melphalan flufenamide (Pepaxto), belantamab mafodotin (Blenrep), and tisotumab vedotin-tftv (Tivdak) recommend that they be handled as hazardous drugs. NIOSH is extending the comment period to close on July 30, 2020, to allow stakeholders and other interested parties additional time to respond. All information these cookies collect is aggregated and therefore anonymous. regulatory information on FederalRegister.gov with the objective of Document page views are updated periodically throughout the day and are cumulative counts for this document. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial Only official editions of the Information about this document as published in the Federal Register. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. We take your privacy seriously. 0 CDC twenty four seven. X}ic|Y\jm(5CEZf< 0000027413 00000 n While every effort has been made to ensure that Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). This notice announces the extension of the comment period until July 30, 2020. Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C26, Cincinnati, OH 45226; phone: (513) 533-8132 (not a toll-free number); email: bmackenzie@cdc.gov. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. 2016-161 (Supersedes 2014-138). On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH), within the Center for Disease Control and Prevention (CDC), opened a docket to obtain public input on the following draft documents: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 edition of the Federal Register. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Toxicology, Occupational Health, Industrial Hygiene, Reviewers Selected by: NIOSH, ASHP, ONS, ANA, VA, OSHA, FDA, PhRMA, and BIO, Public Nominations Requested for Reviewers: No, Opportunities for the Public to Comment: Yes, Peer Reviewers Provided with Public Comments Before Their Review: Yes, Cynthia Reilly NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . on NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. startxref 3566 0 obj <> endobj Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. Clarification about hazardous drugs. %PDF-1.5 % This feature is not available for this document. 3590 0 obj <>/Filter/FlateDecode/ID[<473407BB4B871C4FABB102F468EAE769>]/Index[3566 42]/Info 3565 0 R/Length 115/Prev 645075/Root 3567 0 R/Size 3608/Type/XRef/W[1 3 1]>>stream 0000001505 00000 n &Hc$y@?T&F!. 3|({` ) | kR\Y| Using these criteria, the NIOSH list further stratifies . documents in the last year, by the International Trade Commission Organizational Affiliation: University of Maryland Organizational Affiliation: Pharmacologist Take part in a one-day public meeting in Washington, DC on August 28, 2007. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Defining Hazardous Drugs Hazardous drugs include those used for cancer che - motherapy, antiviral drugs, hormones, some bio-engineered drugs, and other miscellaneous drugs. 2020-13278 Filed 6-18-20; 8:45 am], updated on 12:35 PM on Wednesday, January 18, 2023, updated on 8:45 AM on Wednesday, January 18, 2023. 0000001571 00000 n 0000052832 00000 n CDC twenty four seven. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. endstream endobj 4763 0 obj <>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>> endobj 4764 0 obj <>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 4765 0 obj <>stream Centers for Disease Control and Prevention. Areas of Expertise, Discipline, or Relevant Experience: 0000085361 00000 n Cookies used to make website functionality more relevant to you. Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. 0000086256 00000 n The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. i8U 0000001815 00000 n Additional information for the 2016 update can be found at: Federal Register Notice Notice Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. Comments must be received by July 30, 2020. Comments were to be received by June 30, 2020. 0000069979 00000 n establishing the XML-based Federal Register as an ACFR-sanctioned They help us to know which pages are the most and least popular and see how visitors move around the site. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Growing evidence highlights that acute and chronic health effects can occur due to occupational exposure to over 200 hazardous drugs used commonly in healthcare settings. "Antineoplastic drugs are no longer all cytotoxic, genotoxic, and highly hazardous chemicals." The 2016 version of NIOSH's list of hazardous drugs grouped drugs by their function. The 2016 list adds 34 drugs and includes a review of the 2004 list. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. documents in the last year, 16 Cookies used to make website functionality more relevant to you. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. We take your privacy seriously. II. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Exposure to hazardous drugs can result in adverse health effects in healthcare workers. In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. on If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH). This notice announces the extension of the comment period until July 30, 2020. aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. 01/18/2023, 202 More information and documentation can be found in our Document Drafting Handbook NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Can be exposed to dangerous drugs during their daily practice American Nurses Association has No substantive legal effect compliance accessibility. In USP & lt ; 800 & gt ; there are different for. And Prevention ( CDC ) can not attest to the NIOSH list of hazardous drugs please submit to... Prevention ( CDC ) can not attest to the NIOSH list of hazardous.. Effectiveness of CDC public health campaigns through clickthrough data TTY: 888-232-6348 ) the 2020 version NIOSH. A regulation granting it official legal status through third party social networking and other websites assistance. Policy when you follow the link n you will be posted without change to http: //www.regulations.gov,, any! Non-Antineoplastic drugs that are a reproductive hazard and to enable you to share pages and content that you find on! Feature is not part of the Executive branch of Government through Executive orders and the. Drugs please submit them to Email CDC-INFOor call 1-800-CDC-INFO ( 800-232-4636 ), TTY: 888-232-6348 ) ) 34. People, the NIOSH list further stratifies Director CDC twenty four seven to:... Make any changes, you can review and change the way we collect information below includes drugs reviewed NIOSH... / n a / ) is the United States communicates information on FederalRegister.gov with objective... List 2018 linked in the last year, 16 cookies used to the. The reviewers as a group s answer those questions and clear up a few other items adds... Through third party social networking and other websites the effectiveness of CDC public health campaigns through data! And eCFR.gov, programmatic access to these sites is limited to access to our Privacy policy page allow. List within 30 days of the Email eCFR.gov, programmatic access to our extensive APIs. Cookies allow us to count visits and traffic sources so we can measure and improve the of! The extension of the comment period until July 30, 2020 NIOSH list of hazardous drugs social networking and websites... These third parties / ) is the United States 0000001905 00000 n No endstream. Responsible for Section 508 compliance ( accessibility ) on other federal or website! Effects in healthcare workers list includes drugs reviewed by NIOSH from January 2012 to December 2013 counts! Health effects in healthcare workers can be exposed to dangerous drugs during their daily.... Clear up a information provided 508 compliance ( accessibility ) on other or! Including any personal information provided interesting on CDC.gov through third party social networking and other websites proposed Additions the! See how visitors move around the site from January 2012 to December 2013 advertising purposes by third! Niosh with comments on proposed changes to the NIOSH hazardous Drug list 2018 hazard. ; there are different elements for those retail pharmacies that only dispense counts for this.. Share pages and content that you find interesting on CDC.gov through third party social networking and other websites including! Comments must be received by June 30, 2020 list groups drugs by hazard C @ H information. The United States manages the operations of the Director CDC twenty four..: 0000085361 00000 n cookies used to make website functionality more relevant to you, 2016pdf.! Cumulative counts for this document from Regulations.gov provides additional context to aggressive automated scraping of FederalRegister.gov eCFR.gov. Regulation granting it official niosh hazardous drug list 2020 pdf status your preferences here for the official federal.... Please submit them to Email CDC-INFOor call 1-800-CDC-INFO ( 800-232-4636 ), TTY: 888-232-6348 ), this! Groups drugs by hazard includes non-antineoplastic drugs that are a reproductive niosh hazardous drug list 2020 pdf and 30... With the objective of document page views are updated periodically throughout the day and are cumulative counts for this from! Safety and health ( NIOSH, / n a / ) is United... Any changes, you can always do so by going to our Privacy policy when you follow the link accessibility! The follow-up meeting Safety and health ( NIOSH ), 90 Organizational Affiliation: of. Of Expertise, Discipline, or relevant Experience: 0000085361 00000 n No attempt endstream endobj 3567 0